The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N1-((S)-2-((S)-3-hydroxypyrrolidin-1-yl)-1-phenylethyl)-N1-methyl-N3-(pyridin-3-yl)malonamide ID: ALA425836
PubChem CID: 11440457
Max Phase: Preclinical
Molecular Formula: C21H26N4O3
Molecular Weight: 382.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C(=O)CC(=O)Nc1cccnc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1
Standard InChI: InChI=1S/C21H26N4O3/c1-24(21(28)12-20(27)23-17-8-5-10-22-13-17)19(16-6-3-2-4-7-16)15-25-11-9-18(26)14-25/h2-8,10,13,18-19,26H,9,11-12,14-15H2,1H3,(H,23,27)/t18-,19+/m0/s1
Standard InChI Key: QRMWODNOOLVFGC-RBUKOAKNSA-N
Molfile:
RDKit 2D
28 30 0 0 1 0 0 0 0 0999 V2000
0.5944 -22.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5932 -23.1732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3081 -23.5860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0245 -23.1727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0216 -22.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3063 -21.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3079 -24.4110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5933 -24.8234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5931 -25.6484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1211 -24.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0222 -24.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7368 -24.4114 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4864 -24.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0386 -24.1337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6262 -23.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8192 -23.5905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8590 -24.2201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1209 -23.5857 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8357 -24.8230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5500 -24.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5498 -23.5853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2646 -24.8227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9790 -24.4100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9800 -23.5856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6935 -23.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4090 -23.5853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4066 -24.4146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6925 -24.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 3 1 0
3 4 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
7 8 1 0
14 17 1 6
10 18 2 0
8 9 1 0
10 19 1 0
4 5 1 0
19 20 1 0
8 10 1 0
20 21 2 0
2 3 1 0
20 22 1 0
7 11 1 1
22 23 1 0
5 6 2 0
23 24 2 0
11 12 1 0
24 25 1 0
12 13 1 0
25 26 2 0
6 1 1 0
26 27 1 0
1 2 2 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 382.46Molecular Weight (Monoisotopic): 382.2005AlogP: 1.68#Rotatable Bonds: 7Polar Surface Area: 85.77Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.12CX Basic pKa: 8.23CX LogP: 0.59CX LogD: -0.30Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.19
References 1. Chu GH, Gu M, Cassel JA, Belanger S, Graczyk TM, DeHaven RN, Conway-James N, Koblish M, Little PJ, DeHaven-Hudkins DL, Dolle RE.. (2007) Novel malonamide derivatives as potent kappa opioid receptor agonists., 17 (7): [PMID:17307360 ] [10.1016/j.bmcl.2007.01.053 ]